OpenSAFELY Vaccine Coverage Report

Pfizer / Priority Group 1

Data from combined, up to 2021-03-17.

Vaccinated at 2021-03-17 (%) Vaccinated at 2021-03-17 (n) Population Vaccinated at 2021-03-10 (%) Vaccinated in past week (%)
Overall - 23.9% 72,156 301,882 23.7% 0.2%
Sex Female 25.4% 48,622 191,709 25.1% 0.2%
Male 21.4% 23,534 110,173 21.2% 0.2%
Ethnicity White - British 24.2% 46,550 191,968 24.0% 0.2%
White - Irish 22.6% 567 2,506 21.8% 0.8%
White - Any other White background 22.7% 1,428 6,293 22.5% 0.2%
Mixed - White and Black Caribbean 11.6% 70 602 11.6% 0.0%
Mixed - White and Black African 11.1% 28 252 11.1% 0.0%
Mixed - White and Asian 15.2% 35 231 15.2% 0.0%
Mixed - Any other mixed background 14.5% 70 483 14.5% 0.0%
Asian or Asian British - Indian 22.0% 455 2,065 21.7% 0.3%
Asian or Asian British - Pakistani 15.1% 133 882 15.1% 0.0%
Asian or Asian British - Bangladeshi 15.5% 63 406 15.5% 0.0%
Asian or Asian British - Any other Asian background 20.6% 245 1,190 20.6% 0.0%
Black or Black British - Caribbean 14.1% 322 2,289 14.1% 0.0%
Black or Black British - African 16.9% 238 1,407 16.9% 0.0%
Black or Black British - Any other Black background 10.2% 77 756 10.2% 0.0%
Other ethnic groups - Chinese 23.5% 84 357 23.5% 0.0%
Other ethnic groups - Any other ethnic group 17.5% 203 1,162 16.9% 0.6%
Patients with any other ethnicity code 23.2% 9,058 38,983 23.0% 0.2%
Ethnicity not stated 25.1% 693 2,758 24.4% 0.8%
Ethnicity not recorded 24.8% 11,718 47,166 24.7% 0.2%
Ethnicity (broad categories) White 24.2% 48,566 200,788 24.0% 0.2%
Mixed 14.0% 224 1,596 14.0% 0.0%
South Asian 19.9% 910 4,564 19.8% 0.2%
Black 14.6% 651 4,459 14.4% 0.2%
Other 19.2% 294 1,533 18.7% 0.5%
Unknown 24.2% 21,483 88,914 24.0% 0.2%
Index of Multiple Deprivation 1 (most deprived) 23.7% 14,420 60,872 23.5% 0.2%
2 20.9% 13,160 63,035 20.5% 0.3%
3 23.2% 14,714 63,525 23.0% 0.2%
4 24.8% 14,987 60,522 24.6% 0.2%
5 (least deprived) 27.6% 14,392 52,059 27.5% 0.1%
Unknown 24.7% 455 1,841 24.7% 0.0%
Clinical Risk Groups Patients in Any Clinical Risk Group 23.8% 61,999 260,421 23.6% 0.2%
Patients with Immunosuppression 26.2% 2,415 9,205 26.1% 0.2%
Patients with CKD 27.6% 20,734 75,250 27.3% 0.3%
Patients who have Chronic Respiratory Disease 26.4% 7,371 27,902 26.2% 0.2%
Patients with Diabetes 25.1% 14,329 57,050 24.9% 0.2%
Patients with Chronic Liver disease 22.2% 1,757 7,910 22.0% 0.2%
Patients with CNS Disease (including Stroke/TIA) 23.7% 36,253 153,076 23.5% 0.2%
Patients with Chronic heart disease 26.6% 28,868 108,647 26.3% 0.2%
Patients with Asplenia or Dysfunction of the Spleen 24.5% 567 2,310 24.5% 0.0%
Patients with Wider Learning Disability 12.5% 5,649 45,297 12.4% 0.1%
Patients with Severe Mental Health 18.0% 5,411 30,142 17.8% 0.1%
Other Groups Patients who are shielding (High Risk from COVID-19) 25.5% 54,068 211,806 25.3% 0.2%
Patients with Morbid Obesity 19.9% 1,624 8,176 19.7% 0.2%
Patients who are pregnant 14.3% 21 147 14.3% 0.0%